Tools
Stock profile

ALIGN TECHNOLOGY INC (ALGN)

ALGN · Latest close $163.96 as of Nov 18, 2026 · 13F data as of Jun 30, 2026 (2026 Q2)
Latest close
$163.96
As of Nov 18, 2026
Tracked funds holding
2 of 149
2026 Q2 13F filings
Opened / added
0 / 1
vs previous quarter
Trimmed / exited
1
vs previous quarter

ALIGN TECHNOLOGY INC (ALGN) is held by 2 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 1 fund adding and 1 fund trimming or exiting versus the previous quarter. Latest close $163.96 as of Nov 18, 2026.

Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: none in the last 90 days · Congress to Nov 16, 2026.

Funds
2026 Q2 13F
Fundamentals
Revenue · FY2025
Red flags
none flagged
Short interest
as of Oct 15, 2026
Holdings · Charts · All institutions · Fundamentals · Short interest · Fails to deliver · Insider trading · 5% holders · Planned sales · Politician trading · Committee jurisdiction · Screens & lenses · Signal record · Related stocks · Recent 8-K

Funds holding this

Ruane Cunniff LP · Disciplined Growth Investors — 2 tracked funds hold ALGN. See all holders.

Insider and Congress activity

No insider open-market activity or Congress trades reported for this stock in the recent window. Insider trading · Politician trading.

Often held alongside

INTUITIVE SURGICAL INC (ISRG) · ZIMMER BIOMET HOLDINGS, INC. (ZBH) · Edwards Lifesciences Corp (EW) · ESTABLISHMENT LABS HOLDINGS INC. (ESTA) · MSA Safety Inc (MSA) — stocks the same funds also hold. See all related stocks.

Super-investor holdings · 2026 Q2

FundPortfolio weightSharesChange vs prev. quarter
Ruane Cunniff LP3.07%1,171,455TRIMMED (-2.9%) Q3 filed Nov 16
Disciplined Growth Investors2.24%783,178ADDED (+0.9%) Q3 filed Nov 16

Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.

Price change since quarter-end: -9.9% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.

Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.

Charts

240.52120.252024-11-192026-11-18

Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.

All institutions · Form 13F

Institutions holding674 of 8,857 filers
Long-only filers among them670
Change vs 2026 Q1-10 net · 619 entered · 629 exited
Shares reported, all filers71,895,178
Reported value, all filers$12.1B

Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).

Company fundamentals

ExchangeNasdaq
IndustryOrthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
Revenue · FY2025$4.0B
Net income · FY2025$410.4M
Total assets · FY2025$6.2B
Shares outstanding71,039,852
Market cap (at latest close)$11.6B

Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Jul 31, 2026.

Short interest

Shares short · Oct 15, 20264,147,627
Share of shares outstanding5.84%
Days to cover4.33

Shares short at recent settlements — Jul 31, 2026: 4.2M · Aug 14, 2026: 3.4M · Aug 31, 2026: 3.9M · Sep 15, 2026: 3.9M · Sep 30, 2026: 4.2M · Oct 15, 2026: 4.1M.

Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Jul 31, 2026.

Fails to deliver

Shares failed to deliver · Oct 14, 20260
Share of shares outstanding0.00%
Fails as a share of short interest · Oct 15, 20260.0%

Fails to deliver at recent settlements — Jul 31, 2026: 0 · Aug 14, 2026: 0 · Aug 31, 2026: 0 · Sep 15, 2026: 0 · Sep 30, 2026: 0 · Oct 14, 2026: 0.

Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Jul 31, 2026.

Insider trading · Form 4

Data unavailable — no Form 4 transactions for this ticker were parsed in the last 90 days.

Planned sales · Form 144

FiledSellerRoleShares to sellMarket valueApprox. sale dateSource
Feb 12, 2026John MoriciOfficer7,969$1.5MFeb 12, 2026SEC filing
Nov 25, 2024Wright EmoryDirector2,500$582.4KNov 25, 2024SEC filing
Feb 29, 2024JOSEPH S LACOB TTEEFBO JOSEPH S. LACOB REV TRUSTU/A/D 07-19-2007Director15,000$4.5MFeb 29, 2024SEC filing
Feb 27, 2024JOSEPH S LACOB TTEE FBO JOSEPH S. LACOB REV TRUSTU/A/D 07-19-2007Director10,000$3.1MFeb 27, 2024SEC filing
Feb 7, 2024Wright EmoryDirector2,524$728.2KFeb 7, 2024SEC filing

A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.

5% holders · Schedule 13D/G

FiledFilerFormShares% ownedEvent dateSource
Aug 12, 2026Capital World InvestorsSC 13G/A3,571,4965.0%Jun 30, 2026SEC filing
Aug 12, 2026G. Zachary Gund, as trustee, sole manager or co-managerSC 13G/A1,875,1472.6%Jun 30, 2026SEC filing
Aug 6, 2026FMR LLCSC 13G4,060,032.235.7%Jun 30, 2026SEC filing
May 14, 2026Capital International InvestorsSC 13G/A3,906,9725.5%Mar 31, 2026SEC filing
May 14, 2026Capital World InvestorsSC 13G4,218,5605.9%Mar 31, 2026SEC filing
Apr 29, 2026Vanguard Capital ManagementSC 13G4,975,8206.9%Mar 31, 2026SEC filing
Mar 26, 2026The Vanguard GroupSC 13G/A00.0%Mar 13, 2026SEC filing
Feb 13, 2026Capital International InvestorsSC 13G4,881,5126.8%Dec 31, 2025SEC filing
Jan 21, 2026BlackRock, Inc.SC 13G/A4,113,4425.7%Dec 31, 2025SEC filing
Apr 17, 2025BlackRock, Inc.SC 13G/A5,136,8057.0%Mar 31, 2025SEC filing

One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.

Politician trading · U.S. Congress

Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).

Committee jurisdiction

Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842). Standing committees with jurisdiction over this industry: Senate Committee on Health, Education, Labor, and Pensions, House Committee on Energy and Commerce.

None of the members who traded this stock in the current window sit on these committees.

Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.

Screens & lenses

Financial Screens

· Piotroski — Financial health improved over the past year

· Earnings Quality (Cash Conversion) — Profits that actually come back as cash

· Shareholder Yield — Cash returned through dividends and buybacks

Key figures

· Piotroski — F-score: 7 · Return on assets: 6.6% · Operating cash flow: $593.2M

· Earnings Quality (Cash Conversion) — Cash conversion (3-yr avg): 1.65 · Operating cash flow: $593.2M · Net income: $410.4M

· Shareholder Yield — Shareholder yield: 4.2% · of which dividends: 0.0% · of which buybacks: 4.2%

Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.

Signal record

· Insider BEST — appeared in 2 of the last 20 quarterly lists; latest 2025 Q3, ranked #49 of 50.

Also held by the tracked funds that hold ALGN — ranked by lift, the co-holding pattern described in Methodology: INTUITIVE SURGICAL INC (ISRG) · ZIMMER BIOMET HOLDINGS, INC. (ZBH) · Edwards Lifesciences Corp (EW) · ESTABLISHMENT LABS HOLDINGS INC. (ESTA) · MSA Safety Inc (MSA) · STERIS plc (STE) · Enovis CORP (ENOV) · Cadre Holdings, Inc. (CDRE).

8 of the 8 are same-industry (SIC) fillers: fewer than 4 stocks met the lift rule for this stock.

Recent 8-K filings

FiledItemsSource
Nov 18, 20265.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers · 9.01 Financial Statements and ExhibitsSEC filing
Nov 6, 20261.01 Entry into a Material Definitive Agreement · 2.03 Creation of a Direct Financial Obligation · 9.01 Financial Statements and ExhibitsSEC filing
Oct 28, 20265.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and ExhibitsSEC filing

Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.

Related

INTUITIVE SURGICAL INC (ISRG) · Track Record: how the signals scored · Practice timing on ALGN

One email a week: the week’s new filings and research. Subscribe free

← ALGM  ·  ALGS →

Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.